← FDA ENFORCEMENT
D-0332-2026Class I
HANDELNINE GLOBAL LLC
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
HANDELNINE GLOBAL LLC
Product type
Drug
Status
Ongoing
Report date
2026-02-11
Distribution
Product was distributed to one customer in NY.
Firm state
NJ
Product quantity
4 bottles /30 capsules each
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPAReason for recall
CGMP Deviations: product found to contain lead.
Product description
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Code / lot info
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Other recalls SPEQ maps to Risk Management & CAPA
2026-10-21Class IIHouston Rx LLC2026-10-21Class IICook Incorporated2026-10-21Class IIBaxter Healthcare Corporation2026-10-14Class IIQUANTUM OPS Inc
See all Risk Management & CAPA recalls →Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →